Accounting Beyang Therapeutics Raises Nearly $30 Million Series A To Advance AI Drug Discovery PlatformBy AdminBitAugust 12, 20260 Beyang Therapeutics has raised nearly $30 million in an oversubscribed Series A financing round to advance its AI-powered drug discovery platform and clinical pipeline.
